In a report released today, Ryan Zimmerman from BTIG maintained a Buy rating on Glaukos (GKOS – Research Report), with a price target of ...

In a report released today, Thomas Shrader from BTIG maintained a Buy rating on Denali Therapeutics (DNLI – Research Report), with a price ...

The S&P 500's rally of 1.8% over just the last two sessions is nice, "but not a game changer yet," according to BTIG's technical guru, Jonathan Krinsky. The chart he provides, below, shows the stock ...

Ten-year Treasury yields were hovering just shy of their highest since last May, and the 30-year yield was close to its ...

BTIG Research has recently reduced Fiverr International Ltd (FVRR) stock to Neutral rating, as announced on November 4, 2024, according to Finviz. Earlier, on July 2, 2024, UBS had reduced the stock ...

Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/96.zlI8HlIH.js ...

Here are four large-cap value stocks that growth and income investors may want to consider now. History suggests they will ...

Poseida Therapeutics Inc (PSTX) stock saw a modest uptick, ending the day at $9.56 which represents a slight increase of $0.04 or 0.42% from the prior close of $9.52. The stock opened at $9.52 and ...

Such was the situation with marijuana real estate investment trust (REIT) Innovative Industrial Properties (NYSE: IIPR) in ...

Short seller Hindenburg Research accused Carvana of accounting manipulation and unstable loans. The company denies the ...

US passed Biosecure Act which would ban federal contracts with targeted firms and their business partners. Legislation ...

The industry should save on interest expenses this year as it follows the Fed's lead in cutting rates. The downside is that ...